COVID-19 Update: FDA Approves Phase 3 Clinical Trial For Octagam For Severe Cases

Off Health, Health Information, Human Health, Life Sciences, Medical Daily, Medicine, Natural Health News, Science and Health, Science and Research

Octapharma USA is conducting a phase III clinical trial of Octagam 10% by enrolling people with severe COVID-19 infection.
Read Original Article: COVID-19 Update: FDA Approves Phase 3 Clinical Trial For Octagam For Severe Cases »

About The Author